To the editor: [1]

Menopause

Volumn 14, Issue 2, 2007, Pages 331-334

  Kuhl, Herbert ^a   Wiegratz, Inka ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYTIBOLONE; 3BETA HYDROXYTIBOLONE; 7ALPHA METHYLETHINYLESTRADIOL; 7ALPHA METHYLNORETHISTERONE; CYTOCHROME P450; DRUG METABOLITE; ETHINYLESTRADIOL; TIBOLONE; UNCLASSIFIED DRUG; 7ALPHA METHYL ETHINYLESTRADIOL; 7ALPHA-METHYL ETHINYLESTRADIOL; DRUG DERIVATIVE; ESTRADIOL; PREGNANE DERIVATIVE;

AROMATIZATION; GAS CHROMATOGRAPHY; HUMAN; KNOCKOUT MOUSE; LETTER; LIVER; MASS SPECTROMETRY; NONHUMAN; POSTMENOPAUSE; CHEMISTRY; EPIDEMIOLOGY; FEMALE; HOT FLUSH; NOTE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESTRADIOL; FEMALE; HOT FLASHES; HUMANS; NORPREGNENES; POSTMENOPAUSE;

EID: 34250614303     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000264447.18842.da     Document Type: Letter

References (24)

1. Schoonen WGEJ, Deckers GH, de Gooijer ME, de Ries R, Kloosterboer HJ. Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives. J Steroid Biochem Mol Biol 2000;74:213-222.
2. Bodine PVN, Harris HA, Lyttle R, Komm BS. Estrogenic effects of 7α-methyl-ethinylestradiol: a newly discovered tibolone metabolite. Steroids 2002;67:681-686.
3. Zacharia LC, Jackson EK, Kloosterboer HJ, Imthurn B, Dubey RK. Conversion of tibolone to 7α-methyl-ethinyl estradiol using gas chromatography-mass spectrometry and liquid chromatographymass spectrometry: interpretation and clinical implications. Menopause 2006;13:926-934.
4. Wiegratz I, Sänger N, Kuhl H. Formation of 7α-methyl-ethinyl estradiol during treatment with tibolone. Menopause 2002;4: 293-295.
5. Timmer CJ, Verheul HAM, Doorstam DP. Pharmacokinetics of tibolone in early and late postmenopausal women. Br J Clin Pharmacol 2002;54:101-106.
6. Vos RME, Krebbers SFM, Verhoeven CHJ, Delbressine LPC. The in vivo human metabolism of tibolone. Drug Metab Dispos 2002;30:106-112.
7. Egarter C. Letters to the editor. Menopause 2003;10:102-103.
8. Kuhl H, Wiegratz I. Letters to the editor. Menopause 2003;10:103-105.
9. Davis SR, Simpson ER. Letters to the editor. Menopause 2003;10:105-106.
10. Kuhl H, Wiegratz I. Letters to the editor. Menopause 2003;10:106-107.
11. Simpson ER. Tibolone. Menopause 2003;10:379-380.
12. Kuhl H, Wiegratz I. Tibolone: in reply. Menopause 2003;10:380-381.
13. de Gooyer ME, Oppers-Tiemissen HM, Leysen D, Verheul HAM, Kloosterboer HJ. Tibolone is not converted by human aromatase to 7α-methyl-17α- ethynylestradiol (7α-MEE): analyses with sensitive bioassays for estrogens and androgens and with LCMSMS. Steroids 2003;68:235-243.
14. Yamamoto T, Yoshiji S, Yasuda J, et al. Aromatization of norethindrone to ethynylestradiol in human adult liver. Endocrinol Japon 1986;33:527-531.
15. Urabe M, Yamamoto T, Yoshiji S, Honjo H, Okada H. Aromatization of norethindrone to ethynylestradiol in human adult liver. Steroids 1987;50:607-608.
16. Yamamoto T, Kitawaki J, Shiroshita K, et al. The confirmation of norethindrone aromatization in primary human hepatocytes by the Vitafiber-II cell culture system. Acta Obstet Gynaec Jpn 1988;40:87-89.
17. Reed MJ, Ross MS, Lai LC, Ghilchik MW, James VHT. In vivo conversion of norethisterone to ethynyloestradiol in perimenopausal women. J Steroid Biochem Mol Biol 1990;37: 301-303.
18. Klehr-Bathmann I, Kuhl H. Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. Maturitas 1995;21:245-250.
19. Kuhnz W, Heuner A, Hümpel M, Seifert W, Michaelis K. In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women. Contraception 1997;56:379-385.
20. Jones MEE, Reutens AT, Boon WC, Ederveen AG, Kloosterboer HJ, Simpson ER. The aromatase knockout (ArKO) mouse as a model to study the oestrogenic actions of tibolone [Abstract 75]. In: Proceedings of the 46th Annual Scientific Meeting of the Endocrine Society of Australia, Melbourne. Sydney, Australia: Endocrine Society of Australia, 2003.
21. Sandker GW, Vos RME, Delbressine LPC, Slooff MJH, Meijer DKF, Groothuis GMM. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica 1994;24:143-155.
22. Osawa Y, Yarborough C, Osawa Y. Norethisterone, a major ingredient of contraceptive pills, is a suicide inhibitor of estrogen biosynthesis. Science 1982;215:1249-1251.
23. Guengerich FP. Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs. Am J Obstet Gynecol 1990;163:2159-2163.
24. Kuhl H, Jung-Hoffmann C, Storch A, Fitzner M, Rühl E. New aspects on the mechanism of action of contraceptive steroids - recent pharmacokinetic studies of low dose formulations. Adv Contracept 1991;7(Suppl 3):149-163.